Exact Mass: 737.2566340000001

Exact Mass Matches: 737.2566340000001

Found 14 metabolites which its exact mass value is equals to given mass value 737.2566340000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Mertansine

DM-1(Mertansine)

C35H48ClN3O10S (737.2748778)


D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents

   

Mertansine

11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1^{10,14}.0^{3,5}]hexacosa-10,12,14(26),16,18-pentaen-6-yl 2-(N-methyl-3-sulfanylpropanamido)propanoate

C35H48ClN3O10S (737.2748778)


   

6-hydroxy-galanthindole 6-O-[beta-D-xylopyranosyl(1->2)-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside]|6-hydroxy-galanthindolyloside C

6-hydroxy-galanthindole 6-O-[beta-D-xylopyranosyl(1->2)-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside]|6-hydroxy-galanthindolyloside C

C34H43NO17 (737.2530868000001)


   

Edoxaban tosylate monohydrate

Edoxaban tosylate monohydrate

C31H40ClN7O8S2 (737.2068190000001)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   
   

4-[[(1S)-1-carboxylato-5-[hydroxy-[(E)-3-phenylprop-2-enoyl]amino]pentyl]amino]-2-[2-[[(1S)-1-carboxylato-5-[hydroxy-[(E)-3-phenylprop-2-enoyl]amino]pentyl]amino]-2-oxoethyl]-2-hydroxy-4-oxobutanoate

4-[[(1S)-1-carboxylato-5-[hydroxy-[(E)-3-phenylprop-2-enoyl]amino]pentyl]amino]-2-[2-[[(1S)-1-carboxylato-5-[hydroxy-[(E)-3-phenylprop-2-enoyl]amino]pentyl]amino]-2-oxoethyl]-2-hydroxy-4-oxobutanoate

C36H41N4O13-3 (737.2669996000001)


   

28-dehydroxystreptovaricin F

28-dehydroxystreptovaricin F

C39H47NO13 (737.3047252)


   

[(16Z,18E)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] 2-[methyl(3-sulfanylpropanoyl)amino]propanoate

[(16Z,18E)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] 2-[methyl(3-sulfanylpropanoyl)amino]propanoate

C35H48ClN3O10S (737.2748778)


D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents

   

beta-Gal-(1->4)-alpha-Glc-(1->3)-[alpha-GlcNAc-(1->2)]-alpha-Hep

beta-Gal-(1->4)-alpha-Glc-(1->3)-[alpha-GlcNAc-(1->2)]-alpha-Hep

C27H47NO22 (737.2589602)


   

2-[3-(11-tert-butyl-2,3,6,7-tetrahydro-1H,5H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-12-ium-9-yl)prop-2-en-1-ylidene]-3-(3-carboxypropyl)-3-methyl-1-(3-sulfonatopropyl)indoline-5-sulfonate

2-[3-(11-tert-butyl-2,3,6,7-tetrahydro-1H,5H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-12-ium-9-yl)prop-2-en-1-ylidene]-3-(3-carboxypropyl)-3-methyl-1-(3-sulfonatopropyl)indoline-5-sulfonate

C38H45N2O9S2- (737.2566340000001)


   

2-aminoethyl beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranoside

2-aminoethyl beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranuronosyl-(1->4)-beta-D-glucopyranoside

C26H43NO23 (737.2225768000001)